2015
DOI: 10.1007/s11064-015-1647-5
|View full text |Cite
|
Sign up to set email alerts
|

Neuroprotective Effects of (−)-Epigallocatechin-3-Gallate Against Focal Cerebral Ischemia/Reperfusion Injury in Rats Through Attenuation of Inflammation

Abstract: Stroke is the second leading cause of death among adults worldwide. (-)-Epigallocatechin-3-gallate (EGCG) has been demonstrated to exhibit neuroprotective functions in cerebral ischemia/reperfusion injury. However, the underlying mechanisms in this process and its contribution to the protection function remain unknown. The current study examined the neuroprotective effects of EGCG after transient middle cerebral artery occlusion (tMCAO) in rats. tMCAO for 120 min was induced in male Sprague-Dawley rats treated… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

3
19
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 45 publications
(22 citation statements)
references
References 45 publications
3
19
0
Order By: Relevance
“…In the present study, the level of NO, and the activities of TNOS, iNOS and cNOS were detected 24 h following the induction of cerebral ischemia. The levels of NO, TNOS, iNOS and cNOS significantly increased in the MCAO model group, which is consistent with the results of previous studies ( 8 10 ). The levels of NO, TNOS, iNOS and cNOS significantly decreased in the two IPTF pretreatment groups when compared to the model group.…”
Section: Discussionsupporting
confidence: 92%
See 1 more Smart Citation
“…In the present study, the level of NO, and the activities of TNOS, iNOS and cNOS were detected 24 h following the induction of cerebral ischemia. The levels of NO, TNOS, iNOS and cNOS significantly increased in the MCAO model group, which is consistent with the results of previous studies ( 8 10 ). The levels of NO, TNOS, iNOS and cNOS significantly decreased in the two IPTF pretreatment groups when compared to the model group.…”
Section: Discussionsupporting
confidence: 92%
“…These high levels lead to marked local and systemic inflammatory responses ( 8 , 9 ). Inflammation itself may exacerbate the spread of damage to the ischemic penumbra, increase the levels of inflammatory cytokines and thus, further aggravate brain injury ( 10 ). Therefore, the identification of novel drugs to regulate the inflammatory response is a promising method for the treatment of cerebral ischemic injury.…”
Section: Introductionmentioning
confidence: 99%
“…12-14 EGCG has also been shown to suppress interferon gamma-induced phosphorylation of STAT1 at its Ser 727 and Tyr 701 residues in cancer cells and to suppress cisplatin-induced phosphorylation selectively Ser 727 in response to cisplatin in the cochlea. 4 In aspiration-induced lung tissue injury, pre-treatment with EGCG reduced levels of cytokines (TNFα and IL-1), of activated STAT1 protein, and of phosphorylated protein levels of JAK1 and JAK2, 15 which may be attributed to blockade of INF-γ induced STAT1 activation.…”
Section: Discussionmentioning
confidence: 99%
“…Stroke is the second cause of death and the leading cause of adult neurological disability worldwide 1 3 . Cerebral ischemic stroke accounts for 87% of all stroke cases.…”
Section: Introductionmentioning
confidence: 99%